Iridex (IRIX) Preferred Shares Issued (2025)
Iridex's quarterly Preferred Shares Issued came in at $6.0 million in Q1 2025.
Iridex has reported Preferred Shares Issued for 1 years, with the latest figure at $6.0 million in Q1 2025.
- For the quarter ending Q1 2025, Preferred Shares Issued changed N/A year-over-year to $6.0 million; the trailing twelve-month figure through Jan 2026 stood at $6.0 million (changed N/A YoY), and the FY2026 full-year result was $6.0 million, changed N/A from the prior year.
- Preferred Shares Issued for Q1 2025 stood at $6.0 million.
- The five-year high for Preferred Shares Issued was $6.0 million in Q1 2025, with the low at $6.0 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2025 | 6.00 Mn |
| Mar 29, 2025 | 6.00 Mn |